Wegovy (Semaglutide)

What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.

Coming Soon – Save up to 85%

Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.

Prescription Required

  • Product Details


    Wegovy (semaglutide) is an injectable medication that is used with a reduced-calorie diet and increased exercise to help manage chronic weight in adults who are:

    • Obese (body mass index = 30 kg/m2) OR
    • Overweight (body mass index = 27 kg/m2) with at least one weight-related condition (e.g., high blood pressure, diabetes, high cholesterol)

    Wegovy is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist.

    Fact Table







    Legal status


    Chemical Name


    Elimination half-life

    7 days

    Dosage (Strength)

    0.5mg pen of 0.5mg/0.5ml, 0.25mg pens of 0.25mg/0.5ml, 1mg pens of 1mg/0.5ml, 1.7mg pens of 1.7mg/0.75ml, 2.4mg pens of 2.4mg/0.75ml


    Not Recommended



    Protein binding

    More than 99%

    PubChem CID






    ATC code






    Routes of administration



    Wegovy is available in a pre-filled pen that delivers a single-dose of either 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg.

    Wegovy should be injected subcutaneously into the abdomen, thigh, or upper arm one time a week, on the same day each week. Wegovy may be administered with or without food. If you have any questions about using Wegovy, ask your doctor or pharmacist.

    The typical starting dose is 0.25 mg one time a week for 4 weeks. Your doctor may increase your dose every 4 weeks until you reach 2.4 mg once weekly.

    The maintenance dose is 2.4 mg one time a week.

    If you have type 2 diabetes, be sure to check your blood sugar before starting and during treatment with Wegovy.


    Semaglutide is the active ingredient in Wegovy.


    Do not use Wegovy if you or any member of your family have had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). 

    Do not use Wegovy if you are allergic to semaglutide or any of its other ingredients.



    See full prescribing information for complete boxed warning.

    • In rodents, semaglutide causes thyroid C-cell tumors at clinically relevant exposures. It is unknown whether WEGOVYTM causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined.
    • WEGOVYTM is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors.
    • Before you start treatment with Wegovy, tell your doctor:
      • About all the medications you take, including prescription, over-the-counter, vitamins, and herbal supplements. Do not take Wegovy with other GLP-1 agonists.
      • About your allergies
      • About your health conditions, including:
        • Kidney problems
        • Pancreatic problems
        • Type 2 diabetes
        • History of diabetic retinopathy
        • Have or have had mental health problems
      • If you are pregnant or have plans to become pregnant
      • If you are breastfeeding or have plans to breastfeed
    • Wegovy should be stored in the refrigerator. Do not freeze. Discard the pen after you use it.

    Side Effects

    Wegovy can cause side effects. The most common include nausea, vomiting, diarrhea, constipation, stomach pain, headache, tiredness, dizziness, indigestion, bloating, belching, flatulence, stomach flu, and heartburn.

    These are not all of the potential side effects that can occur with the use of Wegovy. Call your doctor right away if you develop negative or persistent side effects.


    1. Wegovy. Plainsboro, NJ: Novo Nordisk Inc.; 2021.
    2. Once-Weekly Wegovy semaglutide injection. Accessed February 9, 2022.

    IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

    Product Code : 13641

  • Product Reviews


Please wait while the page is loading. Do not hit refresh or the browser back button to avoid any loss of information.

If you have any questions or concerns, please contact our Customer Service team via the chat option on our website or calling us toll free at: 1-800-891-0844